Kansas House Bill HB2230

Kansas 2025-2026 Regular Session

• Introduced: 2/4/25
• Refer: 2/4/25

Caption

Enacting the kratom consumer protection act, defining kratom as a food product, prohibiting the distribution and sale of kratom that is adulterated, requiring persons to be at least 21 years of age to purchase such product, establishing civil fines for violations of the act and requiring the secretary of agriculture to adopt rules and regulations for the administration of the act.

Summary

HB2230 creates the Kansas Kratom Consumer Protection Act and treats kratom products as food products or dietary ingredients for purposes of regulation. The bill defines kratom, kratom extract, processor, retailer, and related terms, and then sets product standards for what may be prepared, distributed, or sold in Kansas. It prohibits kratom products that are adulterated or contaminated with dangerous non-kratom substances, products with excessive residual solvents, products with more than 1% 7-hydroxymitragynine in the alkaloid fraction, and products containing synthetic alkaloids or other synthetically derived kratom compounds. The bill also requires kratom products to carry labeling that includes safe-use directions, a recommended serving size, the manufacturer’s name and address, and a warning that the FDA has not approved kratom for medical use and that pregnant or nursing users should consult a health care professional. In addition, it bars sale or distribution of kratom products to anyone under 21 years of age. The secretary of agriculture is directed to adopt rules and regulations to administer the act, and violations are subject to civil fines of up to $1,000 for a first offense and up to $2,000 for later offenses. In terms of state law impact, the bill would establish a new regulatory framework for kratom in Kansas and place enforcement authority with the Department of Agriculture. It would also incorporate existing state controlled-substance references by defining contamination to include certain substances listed in Kansas drug schedules and their analogs, while creating a specific compliance standard for retailers who rely in good faith on manufacturer or distributor representations. The act would take effect upon publication in the statute book. The overall sentiment reflected in the bill text is consumer-protection oriented rather than prohibition-oriented: it seeks to allow kratom sales while imposing safety, labeling, and age restrictions. Because there are no committee transcripts or recorded votes provided, there is no documented debate or vote-based evidence of support or opposition in the supplied materials. The main policy tension inherent in the bill is between permitting kratom commerce and restricting potentially unsafe or synthetic products, with the age limit and warning-label requirements serving as the primary safeguards.

Impact

HB2230 would add a new chapter of kratom-specific consumer protection rules to Kansas law, regulating kratom as a food product/dietary ingredient rather than banning it outright. It would prohibit adulterated or contaminated products, set composition and labeling standards, restrict sales to persons 21 and older, authorize civil penalties for violations, and require the secretary of agriculture to promulgate implementing regulations. Retailers receive a limited good-faith defense when relying on upstream supplier representations.

Sentiment

The bill’s apparent policy posture is cautious and regulatory, aiming to protect consumers while preserving lawful kratom sales. No committee discussion or voting history was provided, so there is no recorded legislative sentiment beyond the text itself. Based on the bill language, the measure appears designed to appeal to both public-health concerns and those favoring a regulated market.

Contention

The likely points of contention are whether kratom should be regulated as a food product at all, whether the 21-and-over restriction is appropriate, and whether the bill’s product standards are strict enough to address safety concerns. Potentially disputed provisions include the 1% 7-hydroxymitragynine cap, the ban on synthetic alkaloids, and the scope of the retailer good-faith defense. Stakeholders likely to differ include kratom consumers and retailers, public-health advocates, and regulators focused on contamination and youth access.